NCT00385658View on ClinicalTrials.gov

Efficacy of Fluvastatin and Fenofibrate in Comparison to Simvastatin and Ezetimibe in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2007

Conditions
Dyslipidemia
Interventions
DRUG

Fluvastatin extended release, fenofibrate

DRUG

Fixed combination simvastatin/ezetimibe

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharma AG, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY